hameln pharma r&d


Warning: main(/www/htdocs/w008d5e5//LangSwitch.php) [function.main]: failed to open stream: No such file or directory in /www/htdocs/w008d5e5/en/pharma_rd/references/index.php on line 30

Warning: main(/www/htdocs/w008d5e5//LangSwitch.php) [function.main]: failed to open stream: No such file or directory in /www/htdocs/w008d5e5/en/pharma_rd/references/index.php on line 30

Warning: main() [function.include]: Failed opening '/www/htdocs/w008d5e5//LangSwitch.php' for inclusion (include_path='.:/usr/share/php:..') in /www/htdocs/w008d5e5/en/pharma_rd/references/index.php on line 30
 

specialists for pharmaceutical service

 

Picture title: certified...

See also

List of References

Registration record in 5 recent years:

USA:

Successful NDA – registration / 505 (b)(2) with Orphan Drug Status
Antidote / Treatment of contamination through lead, zinc, iron including iron loft diseases, manganese, chromium, plutonium and other radioactive metals

Manufacturing of sterile preparations Europe:

Successful national registrations

  • Germany
    Anaesthesia products, pain killer, muscle relaxant, antibiotic, anti-hypnotics
  • Austria
    Anaesthesia products
  • The Netherlands
    Antidotes; Anaesthesia products;
  • United Kingdom
    Oncology products, pain killer, anaesthesia products, cardiovascular products, anti-hypnotics
  • France
    Anaesthesia products
  • Ireland
    Anaesthesia products

Successful MRP (Mutual Recognition Procedure) with a total of 65 concerned countries
Germany, Austria, Italy, Greece, Spain, Portugal, Belgium, Luxembourg, The Netherlands, United Kingdom, Ireland, Denmark, Sweden, Finland, Norway

Global:

Successful completed procedures:
Middle East, Asia, South-Africa, Australia, New Zealand, South-America

Running procedures
Middle East, Asia, South-Africa, South-America